Trial Profile
A phase I multiple dose study of aderbasib in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2010
Price :
$35
*
At a glance
- Drugs Aderbasib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Incyte Corporation